Fidelity Investments’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-41,228
| Closed | -$678K | – | 5834 |
|
|
2023
Q4 | $678K | Hold |
41,228
| – | – | ﹤0.01% | 2587 |
|
|
2023
Q3 | $320K | Hold |
41,228
| – | – | ﹤0.01% | 2750 |
|
|
2023
Q2 | $214K | Hold |
41,228
| – | – | ﹤0.01% | 2934 |
|
|
2023
Q1 | $221K | Sell |
41,228
-819,910
| -95% | -$4.46M | ﹤0.01% | 2938 |
|
|
2022
Q4 | $3.19M | Hold |
861,138
| – | – | ﹤0.01% | 2247 |
|
|
2022
Q3 | $4.31M | Hold |
861,138
| – | – | ﹤0.01% | 2218 |
|
|
2022
Q2 | $5.03M | Hold |
861,138
| – | – | ﹤0.01% | 2233 |
|
|
2022
Q1 | $6.13M | Hold |
861,138
| – | – | ﹤0.01% | 2304 |
|
|
2021
Q4 | $11.4M | Hold |
861,138
| – | – | ﹤0.01% | 2067 |
|
|
2021
Q3 | $19.8M | Hold |
861,138
| – | – | ﹤0.01% | 1850 |
|
|
2021
Q2 | $37.8M | Hold |
861,138
| – | – | ﹤0.01% | 1563 |
|
|
2021
Q1 | $62.5M | Sell |
861,138
-363,321
| -30% | -$25.8M | 0.01% | 1289 |
|
|
2020
Q4 | $52.9M | Hold |
1,224,459
| – | – | ﹤0.01% | 1293 |
|
|
2020
Q3 | $50.3M | Hold |
1,224,459
| – | – | 0.01% | 1190 |
|
|
2020
Q2 | $73.5M | Hold |
1,224,459
| – | – | 0.01% | 1008 |
|
|
2020
Q1 | $92.2M | Sell |
1,224,459
-2,847
| -0.2% | -$328K | 0.01% | 789 |
|
|
2019
Q4 | $169M | Sell |
1,227,306
-813,459
| -40% | -$98.9M | 0.02% | 717 |
|
|
2019
Q3 | $242M | Hold |
2,040,765
| – | – | 0.03% | 564 |
|
|
2019
Q2 | $286M | Hold |
2,040,765
| – | – | 0.03% | 516 |
|
|
2019
Q1 | $365M | Hold |
2,040,765
| – | – | 0.04% | 408 |
|
|
2018
Q4 | $321M | Buy |
+2,040,765
| New | +$304M | 0.04% | 410 |
|
Fidelity Investments's ORTX Position: Q1 2024 in Review
Fidelity Investments sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 41,228 shares — an estimated $678K sold.
Fidelity Investments first reported a position in ORTX in Q4 2018 and held it in 21 quarters. The position peaked at $365M in Q1 2019. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.
- Fidelity Investments reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
- Fidelity Investments sold 41,228 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $678K.
- Fidelity Investments first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 21 quarters.
- Fidelity Investments's Orchard Therapeutics plc American Depositary Shares position peaked at $365M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.
Based on Fidelity Investments's 13F filing for Q1 2024, filed 13 May 2024.